title: Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case.
authors.forename: Amer
authors.initials: A
authors.lastname: Zeidan
authors.forename: Surabhi
authors.initials: S
authors.lastname: Kakati
authors.forename: Barbara
authors.initials: B
authors.lastname: Anderson
authors.forename: Maurice
authors.initials: M
authors.lastname: Barcos
authors.forename: Meir
authors.initials: M
authors.lastname: Wetzler
mesh_terms: D000328:Adult; D024422:Aneugens / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001549:Benzamides; D002892:Chromosomes, Human, Pair 22; D002897:Chromosomes, Human, Pair 7; D002899:Chromosomes, Human, Pair 9; D018450:Disease Progression; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D009006:Monosomy / Q000175:diagnosis*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D014178:Translocation, Genetic
chemical_list: D024422:Aneugens; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; C498826:nilotinib